The RareCyte® platform for next‐generation analysis of circulating tumor cells

Circulating tumor cells (CTCs) can reliably be identified in cancer patients and are associated with clinical outcome. Next‐generation “liquid biopsy” technologies will expand CTC diagnostic investigation to include phenotypic characterization and single‐cell molecular analysis. We describe here a r...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cytometry A
Asıl Yazarlar: Kaldjian, Eric P., Ramirez, Arturo B., Sun, Yao, Campton, Daniel E., Werbin, Jeffrey L., Varshavskaya, Paulina, Quarre, Steven, George, Tad, Madan, Anup, Blau, C. Anthony, Seubert, Ronald
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2018
Konular:
CTC Technologies and Tools
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6586054/
https://ncbi.nlm.nih.gov/pubmed/30277660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cyto.a.23619
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller